The implication of periodontitis in vascular endothelial dysfunction

European Journal of Clinical Investigation

Volumn 44, Issue 10, 2014, Pages 1000-1009

  Gurav, Abhijit N ^a  

^a Tatyasaheb Kore Dental College and Research Centre   (India)

Author keywords

Endothelial dysfunction; Periodontal bacteria; Periodontal therapy; Periodontitis; Vascular endothelium

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL MARKER;

BACTERIAL INFECTIONS; BIOFILM; CARDIOVASCULAR DISEASES; COMPLICATION; DENTAL PROCEDURE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PERIODONTITIS; PROCEDURES; VASCULAR ENDOTHELIUM;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOFILMS; BIOMARKERS; CARDIOVASCULAR DISEASES; DENTAL CARE; ENDOTHELIUM, VASCULAR; HUMANS; PERIODONTITIS;

EID: 84908701118     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12322     Document Type: Article

References (84)

1. Marsh PD, Devine DA. How is the development of dental biofilms influenced by the host? J Clin Periodontol 2011;38:28-35.
2. Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-81.
3. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005;366:1809-20.
4. Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmür R et al. Oral biofilm architecture on natural teeth. PLoS ONE 2010;5:e9321.
5. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000 2005;38:135-87.
6. Leonhardt A, Carlén A, Bengtsson L, Dahlén G. Detection of periodontal markers in chronic periodontitis. Open Dent J 2011;5:110-15.
7. Ren L, Jiang ZQ, Fu Y, Leung WK, Jin LJ. The interplay of lipopolysaccharide-binding protein and cytokines in periodontal health and disease. J Clin Periodontol 2009;36:619-26.
8. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol 2008;79:1585-91.
9. Tatakis DN, Kumar PS. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am 2005;49:491-516.
10. Münzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 2008;40:180-6.
11. Tousoulis D, Kampoli AM, Tentolouris C, Papageorgiou N, Stefanadis C. The role of nitric oxide on endothelial function. Curr Vasc Pharmacol 2012;10:4-18.
12. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007;115:1285-95.
13. Khazaei M, Moien-afshari F, Laher I. Vascular endothelial function in health and diseases. Pathophysiology 2008;15:49-67.
14. Pate M, Damarla V, Chi DS, Negi S, Krishnaswamy G. Endothelial cell biology: role in the inflammatory response. Adv Clin Chem 2010;52:109-30.
15. Kvietys PR, Granger DN. Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radical Biol Med 2012;52:556-92.
16. Verma S, Lovren F, Dumont AS, Mather KJ, Maitland A, Kieser TM et al. Tetrahydrobiopterin improves endothelial function in human saphenous veins. J Thorac Cardiovasc Surg 2000;120:668-71.
17. Tsioufis C, Thomopoulos C, Soldatos N, Syrseloudis D, Kasiakogias A, Silvestros S et al. The conjoint detrimental effect of chronic periodontal disease and systemic inflammation on asymmetric dimethyl-arginine in untreated hypertensive subjects. Atherosclerosis 2010;208:258-63.
18. Endemann DH, Schiffrin EI. Endothelial dysfunction. J Am Soc Nephrol 2004;15:1983-92.
19. Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications. Cardiology 2012;122:55-68.
20. Sandoo A, van Zanten JJ, Metsios GS, Carroll D, Kitas GD. The endothelium and its role in regulating vascular tone. Open Cardiovasc Med J 2010;4:302-12.
21. Ghiadoni L, Versari D, Giannarelli C, Faita F, Taddei S. Non-invasive diagnostic tools for investigating endothelial dysfunction. Curr Pharm Des 2008;14:3715-22.
22. Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P et al. The assessment of endothelial function: from research into clinical practice. Circulation 2012;126:753-67.
23. Paulus P, Jennewein C, Zacharowski K. Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis? Biomarkers 2011;16:S11-21.
24. Badimon L, Romero JC, Cubedo J, Borrell-Pagès M. Circulating biomarkers. Thromb Res 2012;130:S12-15.
25. Loos BG. Systemic markers of inflammation in periodontitis. J Periodontol 2005;76:2106-15.
26. Nesse W, Abbas F, van der Ploeg I, Spijkervet FKL, Dijkstra PU, Vissink A. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 2008;35:668-73.
27. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-90.
28. Ebersole JL, Stevens J, Steffen MJ, Dawson D III, Novak MJ. Systemic endotoxin levels in chronic indolent periodontal infections. J Periodont Res 2010;45:1-7.
29. Chen YW, Umeda M, Nagasawa T, Takeuchi Y, Huang Y, Inoue Y et al. Periodontitis may increase the risk of peripheral arterial disease. Eur J Vasc Endovasc Surg 2008;35:153-8.
30. Devaraj S, Singh U, Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009;55:229-38.
31. Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 2006;113:2135-50.
32. Iwai T. Periodontal bacteremia and various vascular diseases. J Periodont Res 2009;44:689-94.
33. Huang AL, Vita JA. Effects of systemic inflammation on endothelium dependent vasodilation. Trends Cardiovasc Med 2006;16:15-20.
34. Higashi Y, Goto C, Jitsuiki D, Umemura T, Nishioka K, Hidaka T et al. Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Hypertension 2008;51:446-53.
35. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002;106:1439-41.
36. Ekuni D, Tomofuji T, Sanbe T, Irie K, Azuma T, Maruyama T et al. Periodontitis-induced lipid peroxidation in rat descending aorta is involved in the initiation of atherosclerosis. J Periodontal Res 2009;44:434-42.
37. Ekuni D, Tomofuji T, Sanbe T, Irie K, Azuma T, Maruyama T et al. Vitamin C intake attenuates the degree of experimental atherosclerosis induced by periodontitis in the rat by decreasing oxidative stress. Arch Oral Biol 2009;54:495-502.
38. Brock GR, Butterworth CJ, Matthews JB, Chapple IL. Local and systemic total antioxidant capacity in periodontitis and health. J Clin Periodontol 2004;31:515-21.
39. D'Aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res 2010;89:1241-6.
40. Bostanci N, Belibasakis GN. Porphyromonas gingivalis: an invasive and evasive opportunistic oral pathogen. FEMS Microbiol Lett 2012;333:1-9.
41. Hayashi C, Gudino CV, Gibson FC III, Genco CA. Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol 2010;25:305-16.
42. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S et al. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 2003;23:1405-11.
43. Gibson FC III, Hong C, Chou HH, Yumoto H, Chen J, Lien E et al. Innate immune recognition of invasive bacteria accelerates atherosclerosis in Apolipoprotein E-deficient mice. Circulation 2004;109:2801-6.
44. Brodala N, Merricks EP, Bellinger DA, Damrongsri D, Offenbacher S, Beck J et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs. Arterioscler Thromb Vasc Biol 2005;25:1446-51.
45. Li L, Michel R, Cohen J, DeCarlo A, Kozarov E. Intracellular survival and vascular cell-to-cell transmission of Porphyromonas gingivalis. BMC Microbiol 2008;8:26.
46. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA Jr, Progulske-Fox A. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler Thromb Vasc Biol 2005;25:e17-18.
47. Roth GA, Moser B, Roth-Walter F, Giacona MB, Harja E, Papapanou PN et al. Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 2007;190:271-81.
48. Roth GA, Moser B, Huang SJ, Brandt JS, Huang Y, Papapanou PN et al. Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. J Thromb Haemost 2006;4:2256-61.
49. Yamazaki K, Honda T, Domon H, Okui T, Kajita K, Amanuma R et al. Relationship of periodontal infection to serum antibody levels to periodontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin Exp Immunol 2007;149:445-52.
50. Roth GA, Ankersmit HJ, Brown VB, Papapanou PN, Schmidt AM, Lalla E. Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol Lett 2007;272:106-13.
51. Aoyama N, Suzuki J, Wang D, Ogawa M, Kobayashi N, Hanatani T et al. Porphyromonas gingivalis promotes murine abdominal aortic aneurysms via matrix metalloproteinase-2 induction. J Periodontal Res 2011;46:176-83.
52. Pejcic A, Kesic LJ, Milasin J. C-reactive protein as a systemic marker of inflammation in periodontitis. Eur J Clin Microbiol Infect Dis 2011;30:407-14.
53. Chun YH, Chun KR, Olguin D, Wang HL. Biological foundation for periodontitis as a potential risk factor for atherosclerosis. J Periodontal Res 2005;40:87-95.
54. Shaddox L, Wiedey J, Bimstein E, Magnuson I, Clare-Salzler M, Aukhil I et al. Hyper-responsive phenotype in localized aggressive periodontitis. J Dent Res 2010;89:143-8.
55. Houri-Haddad Y, Wilensky A, Shapira L. T-cell phenotype as a risk factor for periodontal disease. Periodontol 2000 2007;45:67-75.
56. Wang Q, Zhou X, Huang D. Role for Porphyromonas gingivalis in the progression of atherosclerosis. Med Hypotheses 2009;72:71-3.
57. Xu Q, Metzler B, Jahangiri M, Mandal K. Molecular chaperones and heat shock proteins in atherosclerosis. Am J Physiol Heart Circ Physiol 2012;302:H506-14.
58. van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005;5:318-30.
59. Sherer Y, Shoenfeld Y. Mechanisms of disease: atherosclerosis in autoimmune diseases. Nat Clin Pract Rheumatol 2006;2:99-106.
60. van Eden W, Wick G, Albani S, Cohen I. Stress, heat shock proteins, and autoimmunity. Ann NY Acad Sci 2007;1113:217-37.
61. Grundtman C, Kreutmayer SB, Almanzar G, Wick MC, Wick G. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol 2011;31:960-8.
62. Honda T, Oda T, Yoshie H, Yamazaki K. Effects of Porphyromonas gingivalis antigens and proinflammatory cytokines on human coronary artery endothelial cells. Oral Microbiol Immunol 2005;20:82-8.
63. Ford PJ, Gemmell E, Hamlet SM, Hasan A, Walker PJ, West MJ et al. Cross-reactivity of GroEL antibodies with human heat shock protein 60 and quantification of pathogens in atherosclerosis. Oral Microbiol Immunol 2005;20:296-302.
64. Ford PJ, Gemmell E, Chan A, Carter CL, Walker PJ, Bird PS et al. Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol 2006;21:206-11.
65. Choi J, Lee S-Y, Kim K, Choi B-K. Identification of immunoreactive epitope of Porphyromonas gingivalis heat shock protein peptide in periodontitis and atherosclerosis. J Periodont Res 2011;46:240-5.
66. Lee HR, Jun HK, Kim HD, Lee SH, Choi BK. Fusobacterium nucleatum GroEL induces risk factors of atherosclerosis in human microvascular endothelial cells and ApoE (-/-) mice. Mol Oral Microbiol 2012;27:109-23.
67. Hallmon WW, Rees TD. Local anti-infective therapy: mechanical and physical approaches. A systematic review. Ann Periodontol 2003;8:99-114.
68. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002;29:136-59.
69. Kalsi R, Vandana KL, Prakash S. Effect of local drug delivery in chronic periodontitis patients: a meta-analysis. J Indian Soc Periodontol 2011;15:304-9.
70. Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA. Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arteroscler Thromb Vasc Biol 2003;23:1245-9.
71. Higashi Y, Goto C, Hidaka T, Soga J, Nakamura S, Fujii Y et al. Oral infection-inflammatory pathway, periodontitis, is a risk factor for endothelial dysfunction in patients with coronary artery disease. Atherosclerosis 2009;206:604-10.
72. Mercanoglu F, Oflaz H, Oz O, Gökbuget AY, Genchellac H, Sezer M et al. Endothelial dysfunction in patients with chronic periodontitis and its improvement after initial periodontal therapy. J Periodontol 2004;75:1694-700.
73. Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R et al. Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 2005;149:1050-4.
74. Elter JR, Hinderliter AL, Offenbacher S, Beck JD, Caughey M, Brodala N et al. The effects of periodontal therapy on vascular endothelial function: a pilot trial. Am Heart J 2006;151:47.
75. D'Aiuto F, Parkar M, Tonetti MS. Acute effects of periodontal therapy on bio-markers of vascular health. J Clin Periodontol 2007;34:124-9.
76. Tonetti MS, D'Aiuto F, Nibali L, Donald A, Storry C, Parkar M et al. Treatment of periodontitis and endothelial function. N Engl J Med 2007;356:911-20.
77. Pischon N, Hägewald S, Kunze M, Heng N, Christan C, Kleber BM et al. Influence of periodontal therapy on the regulation of soluble cell adhesion molecule expression in aggressive periodontitis patients. J Periodontol 2007;78:683-90.
78. Blum A, Kryuger K, MashiachEizenberg M, Tatour S, Vigder F, Laster Z et al. Periodontal care may improve endothelial function. Eur J Intern Med 2007;18:295-8.
79. Piconi S, Trabattoni D, Luraghi C, Perilli E, Borelli M, Pacei M et al. Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness. FASEB J 2009;23:1196-204.
80. Li X, Tse HF, Yiu KH, Li LSW, Jin L. Effect of periodontal treatment on circulating CD341 cells and peripheral vascular endothelial function: a randomized controlled trial. J Clin Periodontol 2011;38:148-56.
81. D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004;83:156-60.
82. Li X, Tse HF, Jin LJ. Novel endothelial biomarkers: implications for periodontal disease and CVD. J Dent Res 2011;90:1062-90.
83. Slots J. Low-cost periodontal therapy. Periodontol 2000 2012;60:110-37.
84. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation 2012;125:2520-44.